Proposed clinical management of pregnancies after combined screening for pre-eclampsia at 30-34 weeks' gestation

Competing risks model in screening for preeclampsia by maternal factors and biomarkers at 30–34 weeks’ gestation

(2016) Andreas Tsiakkas et al.   AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY

Safety and pharmacokinetics of pravastatin used for the prevention of preeclampsia in high-risk pregnant women: a pilot randomized controlled trial

(2016) Maged M. Costantine et al.   AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY

Predictive Value of the sFlt-1:PlGF Ratio in Women with Suspected Preeclampsia

(2016) Harald Zeisler et al.   NEW ENGLAND JOURNAL OF MEDICINE

Competing risks model in screening for preeclampsia by maternal characteristics and medical history

(2015) David Wright et al.   AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY

Serum soluble fms-like tyrosine kinase-1 in the three trimesters of pregnancy: effects of maternal characteristics and medical history

(2015) A. Tsiakkas et al.   ULTRASOUND IN OBSTETRICS & GYNECOLOGY

Uterine artery pulsatility index in the three trimesters of pregnancy: effects of maternal characteristics and medical history

(2015) A. Tayyar et al.   ULTRASOUND IN OBSTETRICS & GYNECOLOGY

Serum placental growth factor in the three trimesters of pregnancy: effects of maternal characteristics and medical history

(2015) A. Tsiakkas et al.   ULTRASOUND IN OBSTETRICS & GYNECOLOGY

Mean arterial pressure in the three trimesters of pregnancy: effects of maternal characteristics and medical history

(2015) A. Wright et al.   ULTRASOUND IN OBSTETRICS & GYNECOLOGY

Onset threshold of the plasma levels of soluble fms-like tyrosine kinase 1/placental growth factor ratio for predicting the imminent onset of preeclampsia within 4 weeks after blood sampling at 19–31 weeks of gestation

(2013) Akihide Ohkuchi et al.   HYPERTENSION RESEARCH

Prevention of perinatal death and adverse perinatal outcome using low-dose aspirin: a meta-analysis

(2013) S. Roberge et al.   ULTRASOUND IN OBSTETRICS & GYNECOLOGY

Angiogenic Factors and the Risk of Adverse Outcomes in Women With Suspected Preeclampsia

(2012) Sarosh Rana et al.   CIRCULATION

A Competing Risks Model in Early Screening for Preeclampsia

(2012) David Wright et al.   FETAL DIAGNOSIS AND THERAPY

Protocol for Measurement of Mean Arterial Pressure at 11-13 Weeks' Gestation

(2012) L.C.Y. Poon et al.   FETAL DIAGNOSIS AND THERAPY

Maternal plasma concentrations of angiogenic/anti-angiogenic factors are of prognostic value in patients presenting to the obstetrical triage area with the suspicion of preeclampsia

(2012) Tinnakorn Chaiworapongsa et al.   Journal of Maternal-Fetal & Neonatal Medicine

Placental Growth Factor for the Prediction of Adverse Outcomes in Patients with Suspected Preeclampsia or Intrauterine Growth Restriction

(2012) Jeanne Sibiude et al.   PLoS One

The sFlt-1/PlGF ratio in different types of hypertensive pregnancy disorders and its prognostic potential in preeclamptic patients

(2011) Stefan Verlohren et al.   AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY

Turning the Pyramid of Prenatal Care

(2011) Kypros H. Nicolaides   FETAL DIAGNOSIS AND THERAPY

The prognostic role of uterine artery Doppler studies in patients with late-onset preeclampsia

(2009) Tullio Ghi et al.   AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY

Induction of labour versus expectant monitoring for gestational hypertension or mild pre-eclampsia after 36 weeks' gestation (HYPITAT): a multicentre, open-label randomised controlled trial

(2009) Corine M Koopmans et al.   LANCET